Transcript
![Page 1: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/1.jpg)
Points to consider for environmental risk assessment of the use of living modified organisms; PMDA perspectives on type 1 use approval and type 2 use confirmation under “Cartagena Law”
Special Symposium II: Biosafety Regulations in Gene Therapy (J)
![Page 2: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/2.jpg)
2
![Page 3: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/3.jpg)
Presentation Outline
3
![Page 4: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/4.jpg)
GILSP GILSP
4
![Page 5: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/5.jpg)
5
![Page 6: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/6.jpg)
WHO Certification Scheme on the Quality of Pharmaceutical Moving in International Commerce
6
![Page 7: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/7.jpg)
••
7
![Page 8: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/8.jpg)
••
8
![Page 9: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/9.jpg)
CHO
9
![Page 10: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/10.jpg)
10
![Page 11: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/11.jpg)
•
•
•11
![Page 12: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/12.jpg)
12
![Page 13: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/13.jpg)
13
![Page 14: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/14.jpg)
14
![Page 15: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/15.jpg)
•
•
•
•
•
•
15
![Page 16: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/16.jpg)
30
16
![Page 17: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/17.jpg)
17
![Page 18: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/18.jpg)
••
•
••
•
•18
![Page 19: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/19.jpg)
•••
••••••
19
![Page 20: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/20.jpg)
••••
••
••••• J-BCH
http://www.biodic.go.jp/bch/20
![Page 21: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/21.jpg)
21
![Page 22: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/22.jpg)
22
![Page 23: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/23.jpg)
PMDA Consultation…
Conclusion
23
![Page 24: ¡ á µm K · K v ® ñ ¨ ª ¸ · V ÜPresentation Outline 3 G9GyGMGfGX 2Fþ /(Ô W G9GyGMGfGX1 iH $ &àH G9GyGMGfGX 2H $ &àH ; ç / 0d NH H %, ¹ %, çH %Ê'26ä$Î '%, ç H eF¸#](https://reader034.vdocument.in/reader034/viewer/2022050302/5f6b29a654edaf65402db212/html5/thumbnails/24.jpg)
http://www.pmda.go.jp/review-services/drug-reviews/cartagena-act/0003.html